Increased plasma levels of damage-associated molecular patterns during systemic anticancer therapy in patients with advanced lung cancer-Reference-Cited by-同舟云学术

Increased plasma levels of damage-associated molecular patterns during systemic anticancer therapy in patients with advanced lung cancer

Published:2021-06 Issue:6 Volume:10 Page:2475-2486
ISSN:2218-6751
Container-title:Translational Lung Cancer Research
language:
Short-container-title:Transl Lung Cancer Res

Author:

Inoue Hiroyuki,Tsutsumi Hirono,Tanaka Kentaro,Iwama Eiji,Shiraishi Yoshimasa,Hirayama Aiko,Nakanishi Takayuki,Ando Hiroyuki,Nakajima Maako,Shinozaki Seiji,Ogata Hiroaki,Uryu Kazuyasu,Okamura Koji,Kimura Shinichi,Ogawa Tomohiro,Ota Keiichi,Yoneshima Yasuto,Hamada Naoki,Nakanishi Yoichi,Okamoto Isamu

Publisher

AME Publishing Company

Subject

Oncology

Link

https://tlcr.amegroups.com/article/download/52318/pdf

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The war between the immune system and the tumor - using immune biomarkers as tracers;Biomarker Research;2024-05-30

2. Potential of fluoropyrimidine to be an immunologically optimal partner of immune checkpoint inhibitors through inducing immunogenic cell death for thoracic malignancies;Thoracic Cancer;2023-12-26

3. Variation of Plasma Damage-Associated Molecular Patterns in Patients with Advanced Solid Tumors after Standard of Care Systemic Treatment;Cancer Investigation;2023-11-24

4. Predictive Impact of Diffuse Positivity for TTF-1 Expression in Patients Treated With Platinum-Doublet Chemotherapy Plus Immune Checkpoint Inhibitors for Advanced Nonsquamous NSCLC;JTO Clinical and Research Reports;2023-11

5. Immunosurveillance in clinical cancer management;CA: A Cancer Journal for Clinicians;2023-10-25